Indonesia vs Serbia: Cause of death, by non-communicable diseases, ages 0-4, female
Indonesia
30.9%
in 2021
Serbia
30.7%
in 2021
Indonesia rank
93rd
Serbia rank
94th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Indonesia
- Serbia
How they compare
Indonesia currently reports 30.9% against 30.7% in Serbia, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Serbia ahead.
Indonesia ranks 93rd and Serbia ranks 94th of 185 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Indonesia | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.8% | 31.7% | 19.9% | Serbia |
| 2010s | 23.5% | 30.5% | 6.9% | Serbia |
| 2020s | 30.8% | 30.0% | 0.8% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Indonesia or Serbia?
- Indonesia, at 30.9% against 30.7% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Indonesia and Serbia?
- 0.2%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Indonesia and Serbia rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Indonesia ranks 93rd and Serbia ranks 94th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.